Riskpilot← Back to searchSign inGet full accessMB Scientific Holding AB
ABActiveOrg 5568202914Economic activity was not specified by tax authority · NACE 0000Est. 20100 employees
Revenue 2024
SEK 0
EBITDA margin
—
-18% vs 2023
Equity ratio
67.8%
Financial strength
Net profit 2024
SEK 988K
0% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -13K | -18% |
| Net profit | SEK 988K | +0% |
| Total assets | SEK 4,3M | +23% |
| Equity | SEK 2,9M | +7% |
| Employees | 0 | — |
Legal name
MB Scientific Holding AB
Org number
5568202914
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
30 september 2010
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Baltzer, Nils Peter Oscar Matsuki, Mitsuse
Company purpose
Bolaget skall direkt eller indirekt, äga och förvalta värdepapper, fastigheter och därmed förenlig verksamhet.
Address
Email
mitsuse.matsuki@mbscientific.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −5 | −12 | −10 | −11 | −13 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −5 | −12 | −10 | −11 | −13 |
| Net financials | 2 000 | — | — | 1 001 | 1 001 |
| Profit before tax | 2 025 | 0 | 0 | 990 | 988 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 2 025 | 0 | 0 | 990 | 988 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 820 | 3 281 | 2 759 | 3 515 | 4 332 |
| Equity | 2 561 | 2 561 | 2 561 | 2 752 | 2 939 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 259 | 720 | 198 | 763 | 1 393 |
| Total debt | 1 259 | 720 | 198 | 763 | 1 393 |
EBITDA margin
-1300000.0%
This company
15.8%
Market median
-8227948% vs market
20202024
Equity ratio
67.8%
This company
38.2%
Market median
+77% vs market
20202024
Return on equity
33.6%
This company
18.4%
Market median
+83% vs market
20202024
Net profit margin
98800000.0%
This company
8.1%
Market median
+1219752986% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MM Chief Executive Officer | Chief Executive Officer | 2022 |
JK | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MB Scientific Holding AB 
MBS JAPAN CO LTDBoard members of MB Scientific Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mitsuse Matsuki | Chief Executive Officer | 0 companies |
| Johanna Katarina Boive | Audit | 0 companies |
| Nils Peter Oscar Baltzer | Board of Directors | 0 companies |